Sanofi Revival Depends on Outsider With a Nose for Big Drugs

(Bloomberg) -- French pharma giant Sanofi is counting on Paul Hudson, a British citizen with a background in sales, rather than science, to revive its slumping stock price and a pipeline that’s bee...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.